Research & Commentary
Research-grounded commentary on IVF emotional support, Singapore women's health policy, prevention economics, and AI in healthcare. Written by Ivy Young, Co-founder & CEO of Amiya.
· Policy · Mental Health · Singapore
Singapore's MediSave withdrawal limits for CDMP mental health conditions just rose to $700–$1,000/year. We welcome the financing, but the CDMP still funds reactive treatment, not the preventative emotional support that catches distress before it becomes a crisis.
Read more· AI Regulation · Healthcare · Singapore
Singapore is the first country to reach WHO Maturity Level 4 for medical device regulation. Regulatory clarity is the bedrock — but technology alone won't heal patients. Patients need agency and trust, not just accuracy.
Read more· Prevention Economics · Women's Health · Singapore
Singapore's medical inflation is projected at 16.9% in 2026 — the highest in APAC. Budget 2026's preventive subsidies are a necessary response, but a subsidy for a test doesn't solve the emotional "toxicity" of the treatment that follows.
Read more· Policy · Genetic Testing · HBOC
MOH will subsidise HBOC genetic testing from December 2026 and cover preventive surgery under MediShield Life for the first time. But a predictive system that identifies risk without readiness support leaves women alone with the hardest decision of their lives.
Read moreGet early access to Amiya and new research on emotional infrastructure for women's health.
JOIN WAITLIST